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ABSTRACT
Non-homologous end-joining (NHEJ), the major
repair pathway for DNA double-strand breaks
(DSB) in mammalian cells, employs a repertoire of
core proteins, the recruitment of which to DSB-ends
is Ku-dependent. Lack of either of the core compo-
nents invariably leads to a repair deficiency. There
has been evidence that an alternative end-joining
operates in the absence of the core components.
We used chromosomal reporter substrates to spe-
cifically monitor NHEJ of single I-SceI-induced-DSB
for detailed comparison of classical and alternative
end-joining. We show that rapid repair of both
compatible and non-compatible ends require
Ku-protein. In the absence of Ku, cells use a slow
but efficient repair mode which experiences
increasing sequence-loss with time after DSB in-
duction. Chemical inhibition and PARP1-depletion
demonstrated that the alternative end-joining
in vivo is completely dependent upon functional
PARP1. Furthermore, we show that the requirement
for PARP1 depends on the absence of Ku but not
on DNA-dependent protein kinase (DNA-PKcs).
Extensive sequencing of repair junctions revealed
that the alternative rejoining does not require long
microhomologies. Together, we show that mamma-
lian cells need Ku for rapid and conservative NHEJ.
PARP1-dependent alternative route may partially
rescue the deficient repair phenotype presumably
at the expense of an enhanced mutation rate.
INTRODUCTION
Non-homologous end-joining (NHEJ) is the prevailing
pathway for repair of DNA double-strand breaks (DSB)
in mammalian cells. NHEJ is executed by two core pro-
tein complexes: the DNA-dependent protein kinase
(DNA-PKcs) complex composed of the Ku70/Ku80
heterodimer together with the catalytic subunit of the
DNA-PKcs and a second complex of ligase IV and its
co-factors XRCC4 and XLF (also known as Cernunnos)
(1). If the DSB ends are not simply ligatable, terminal
nucleotides are modiﬁed or removed by phosphokinases
or nucleases such as PNK and Artemis and sequence gaps
are replenished by polymerase   orm (2–4). Lack of any of
the core components invariably creates a severe DSB
repair defect and substantial sensitivity to ionizing radi-
ation and various DNA damaging drugs like topoisomer-
ase II inhibitors (5–9). Although most of the core
components proved biochemically to be essential for the
end-joining process, it was acknowledged for many years
that cells completely lacking these proteins still rejoin the
majority of radiation-induced DSBs (6,10–13). Using
chromosomal reporter substrates that speciﬁcally
monitor end-joining processes, we and others found that
Ku-deﬁcient and wild-type yeast and mammalian cells
were equally capable of rejoining single I-SceI- and
HO-induced breaks (14–18). This eﬃcient end-joining
has been ascribed to an alternative end-joining pathway,
also named backup end-joining (B-NHEJ), which not only
executes DSB repair but also class switch and to some
extent V(D)J recombination (19–24). Genetic and bio-
chemical in vitro analyses revealed that the alternative
end-joining mode employs ligase III together with
XRCC1, PNK and PARP1 (4,20,25). Accordingly,
chemical inhibition of PARP1 signiﬁcantly compromised
the rejoining of episomal substrates in ligase IV- and
Ku80-deﬁcient cells (26). However, it is hitherto not
clear whether the alternative end-joining route physically
requires PARP1 for DSB repair in the chromosomal
context.
Notably, the exquisite eﬃciency of Ku-independent
end-joining was only observed for breaks with
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compatible ends was Ku-dependent. This raised the pos-
sibility that the alternative repair process prefers
non-compatible ends which require further processing
before ligation. Enforced recruitment of additional
proteins into the repair complex including nucleases and
polymerases (27,28) may increase the local stability of the
junction and hence the probability of successful
end-connection.
In this study, we used recently developed chromosomal
reporter substrates to decipher genetics and structural
requirements for Ku-dependent and independent end-
joining. We describe that complementary and non-
complementary ends similarly need Ku for rapid repair.
In the absence of Ku, the cells employ a slow but
error-prone alternative end-joining mode which is com-
pletely PARP1-dependent but does not need extensive
microhomologies.
MATERIALS AND METHODS
Cell lines
The hamster cell lines CHOK1 (wild-type) and xrs5
(Ku80-deﬁcient) were grown in a-medium (Gibco-
Invitrogen) supplemented with 5% fetal calf serum,
100U/ml penicillin and 100mg/ml streptomycin at 37 C
with 5% CO2. AA8 and V3 hamster cells were kindly
provided by M. Lo ¨ brich, CHO9 and DNA-PK-deﬁcient
XR-C1 cells were a generous gift of M. Z. Zdzienicka.
Chemicals
The inhibitors 1,5-dihydroxyisoquinolinediol (DIQ),
NU7026 and NU1025 were all purchased from Sigma-
Aldrich.
Repair substrates
Two GFP-based repair substrates (pEJ and pEJ2) were
used to investigate NHEJ in the chromosomal context as
described previously (17). pEJ contains two repeat I-SceI
recognition sites in inverted orientation which create
double-stranded (ds)-ends that are non-cohesive. pEJ2
was newly cloned in order to create fully complementary
DSB overhangs (Figure 1). Brieﬂy, the proximal I-SceI
recognition site was removed as EcoRI-HindIII fragment
from the pEJ plasmid. A new ds-oligonucleotide (EcoRI-A
TTACCCTGTTATCCCTAGTGCAC-HindIII) was re-
inserted that carried the I-SceI-site in the same direction
as the distal copy. The advantage of this reporter system is
that it is independent of how the ends are rejoined as long
as any repair-associated deletions are no longer than
160bp. The critical distance for base loss is reached at
the transcription initiation site and the GFP open
reading frame (ORF) (86-bp upstream of the ﬁrst and
76-bp downstream of the second I-SceI site, respectively).
Although in most cases both I-SceI sites are cut in vivo, the
system allows to monitor single cleavage leading to
in-frame shift of both ATGs, as described (9,29) (e.g.
Supplementary Figure S1).
For stable chromosomal integration 0.5mg of pEJ or
pEJ2 linearized by AﬂIII were electroporated into the
hamster cells as described (9). The cells were then grown
in 14mg/ml of G418 for 2weeks. For each cell line and
repair substrate, 30–60 individual colonies were picked,
expanded and tested for green ﬂuorescence after transient
transfection of I-SceI expression vector as described
earlier (17).
DSB-repair reporter assay
The cells containing single stably integrated copies of
either repair substrate were electroporated with 50mgo f
the I-Sce-I expression vector pCMV3xnls-I-SceI (17) to
induce DSBs or with pCMV-Neo as a control. After
0–96h of transfection, cells were assessed for green ﬂuor-
escence by ﬂow cytometry (FACScan, BD Bioscience).
For further analysis of the individual NHEJ events,
GFP-positive cells were sorted (FACS Aria, BD
Bioscience) and proceeded in either of two ways: (i) cells
were reseeded, raised to individual colonies and further
expanded for DNA isolation (DNeasy tissue Kit,
Qiagen). DNA of individual clones was ampliﬁed by
PCR using the primers P1 and P2 that ﬂank the I-Sce-I
cleavage sites (forward 50-GCAAATGGGCGGTAGGC
GTGTA-30, reverse 50-TCGGGCATGGCGGACTTG
AA-30). PCR conditions were 35 cycles at (96 C for 20s,
68 C for 20s, and 72 C for 80s) and an extension for
7min at 72 C. Alternatively, (ii) total genomic DNA of
the entire sorted cell population was isolated and sub-
jected to PCR. The mixtures of those PCR products
were ligated into the TOPO-cloning vector (TOPO TA
cloning kit, Invitrogen), according to the manufacturer’s
protocol and transformed into bacteria (one shot TOP10
competent Escherichia coli, Invitrogen). Single bacterial
clones were scraped oﬀ the plate, directly subjected to
PCR using the primers P1 and P2. PCR conditions are
the same as above except for a preceding 10-min incuba-
tion for bacterial lysis at 96 C. PCR products from either
of two procedures were subjected to sequencing using an
automated ABI 3100 sequencer, (Applied Biosystems-
Hitachi).
To assess the transfection eﬃciency, 30mg of pEGFP-
N1 (Clontech) were electroporated into both strains and
analyzed by FACS 24h later. CHOK1 and xrs5 showed
70.8±3.9 and 64.2±8.4% of green ﬂuorescent cells,
respectively. All subsequently given repair results are cor-
rected for the 1.1-fold lower transfection eﬃciency of xrs5
cells.
PARP1 down-regulation by siRNA and western blot
Cells were transfected with the previously described
siRNA sequence (50-GGGCAAGCACAGUGUCAA-30)
to target the hamster PARP1 transcript (30). 50-UAGGC
AUUGCGCGUGUGUC-30 (non-targeting RNA) was
used as control. Cells were transfected using Trans-
IT-TKO (Mirus, USA) according to the manufacturer’s
protocol. The protein expression was monitored by
western blotting according to standard procedures (9)
using anti-PARP1 mouse monoclonal antibody (Enzo
life sciences, Germany) and anti-actin antibodies
6066 Nucleic Acids Research, 2010,Vol.38, No. 18(Sigma). Protein signals were visualized using the ECL
detection kit (Amersham).
Colony formation assay
The eﬀect of PARP1 inhibition on the radiosensitivity was
assessed by colony formation. Cells were seeded and
incubated for about 2–3h to allow adhesion. Thereafter,
speciﬁc PARP competitive inhibitor (75mM DIQ or
300mM NU1025) was added and the cells were incubated
at 37 C for 2h before irradiation. After X-irradiation
(200keV, 15mA, additional 0.5mm Cu ﬁlter at a dose
rate of 2Gy/min), the cells were incubated for 2weeks
with/without PARP inhibitor for colony formation. The
surviving fraction of irradiated cells was normalized to the
plating eﬃciency of non-irradiated controls.
Immunoﬂuorescence staining of PAR moieties
Cells grown on slides were treated with or without PARP
inhibitors and subsequently irradiated with 20Gy. After
20min, cells were ﬁxed using 4% paraformaldehyde in
PBS for 30min at room temperature. The slides were
then blocked with 1% BSA in PBS for 30min at RT
and incubated with anti-PAR monoclonal IgG (clone
C2-10, Trevigen Inc. MD, USA) for 1h (1:100 dilution
in 0.5% BSA/0.1% Tween 20 in PBS). After washing,
Alexa ﬂuor 594-conjugated anti-mouse monoclonal IgG
(1:600) was used as secondary antibody. Slides were
counterstained with DAPI, examined and photographed
under a ﬂuorescent microscope (Axioplan2, Zeiss,
Germany, Excitation at 590/617nm).
RESULTS
Alternative end-joining is slow and error-prone
The Ku protein is a well-established essential enjoining
factor. However, we and others have recently found that
DSB with non-complementary ends were equally well
rejoined by clones of wild-type and Ku-deﬁcient rodent
cells (14–18). In a series of experiments, using reporter
constructs previously designed to speciﬁcally monitor
chromosomal NHEJ (9,17), we sought to elucidate this
apparent contradiction. The system makes use of the
green ﬂuorescent protein (GFP), the translation of which
is only activated after successful rejoining of two nearby
I-SceI-induced DSBs (Figure 1), which is then monitored
by ﬂow cytometry. Single copies of the reporter pEJ
(Figure 1) (17) were stably integrated into CHOK1 and
xrs5 (Ku80-deﬁcient) hamster cells. NHEJ eﬃciency 24h
after transient expression of I-SceI was assessed in 10–13
independent clones of either cell line to appreciate
inter-clonal variation that possibly impacts on those
reporter assays (Figure 2). Despite substantial variations,
CHOK1-pEJ cells showed on average 4-fold higher fre-
quency of GFP-positive cells compared to xrs5-pEJ
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Figure 1. Structure of the NHEJ reporter constructs pEJ and pEJ2. GFP translation is prevented by insertion of an artiﬁcial ATG (start codon) into
the 50-untranslated region between CMV promoter and the ORF. The artiﬁcial ATG is not in frame with the original ATG (17). Two repeat I-SceI
recognition sequences (bold characters) ﬂank the artiﬁcial ATG either in direct (pEJ2) or in inverted orientation (pEJ). Simultaneous cleavage of
both I-SceI sites leads to pop out of the artiﬁcial ATG (middle) leaving either non-compatible ends (pEJ) or fully compatible ends (pEJ2). Repair of
the I-SceI-induced DSB by NHEJ restores GFP translation leading to green ﬂuorescence.
Nucleic Acids Research, 2010,Vol.38, No. 18 6067(Figure 2A) (3.0±0.6 versus 0.71±0.1%, Mann–Whitney
test P=0.0025).
The structure of the double-stranded ends might aﬀect
the requirement for the Ku-protein (14,15). In order to
test this possibility, we employed a second substrate
pEJ2 which, in contrast to pEJ, provided full complemen-
tary ends (Figure 1). However, similar diﬀerences between
both strains were observed for rejoining of these
compatible ends (Figure 2B, 5.47±1.1% GFP-positive
CHOK1-pEJ2 cells versus 1.5±0.3% GFP-positive
xrs5-pEJ2 cells, P=0.0012). Here, we investigated rela-
tively short repair intervals compared to the preceding
studies where repair eﬃciency was monitored after 48h
or later (15–18). In order to further understand the
impact of the repair time, we analyzed the kinetics of
GFP-positive cells between 6 and 96h post-transfection
(Figure 2C). In wild-type cells, the earliest repair events
were found after only 6h. The number of GFP-positive
cells then rapidly increased with similar kinetics for
non-cohesive and cohesive ends and reached a plateau
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Figure 2. Alternative end-joining pathway is eﬃcient but slow for both compatible and non-compatible ends. Ten to thirteen independent clones of
CHOK1 and xrs5 cells harboring either pEJ (A) or pEJ2 (B) were transfected with the I-SceI-expressing vector. After a 24-h repair interval the
fraction of GFP-positive/total cells (%GFP
+) was measured by ﬂow cytometry. Hatched columns represent mean values (±SE). xrs5-pEJ clone #11
was not included as deviation from others was larger than 2 . NHEJ eﬃciency for both ends and was signiﬁcantly lower in xrs5 than in CHOK1 cells
(Mann–Whitney, P=0.001). (C) NHEJ kinetics for non-cohesive (left panel) and cohesive (right panel) ends. Cells were harvested at diﬀerent time
intervals after transfection and analyzed for GFP
+. The mean (±SE) values of three to four representative clones of each variant (CHOK1-pEJ #3,
40, 75; CHOK1-pEJ #33, 39, 48; xrs5pEJ #20, 23, 26, 59; and xrs5-pEJ2 #9, 10, 12) are shown. Diﬀerences between the two strains were signiﬁcant
only after 24h (Mann–Whitney, P=0.0025).
6068 Nucleic Acids Research, 2010,Vol.38, No. 18after 48h. In contrast, repair in Ku80-deﬁcient cells was
delayed by more than 6h and GFP-positive cells
accumulated more slowly than in CHOK1 cells.
However, rejoining in xrs5 cells continued signiﬁcantly
beyond 24h and the number of GFP-positive events
almost reached wild-type levels after 48h, conﬁrming
our previous observations (17,18). After 96h, repair in
xrs5 cells appeared to be even more eﬃcient than in
wild-type cells suggesting that Ku-independent end-
joining includes the possibility to rejoin open breaks
very lately after damage induction. However, the diﬀer-
ences between wild-type and mutants at 96h were statis-
tically not signiﬁcant. As expected from in vitro results
(31), repair of fully compatible ends was slightly (n.s.)
more eﬃcient than of non-complementary ends.
The slower kinetics of the end-joining process in xrs5
cells means that DSBs stayed open for long which might
aﬀect end stability. Given the time between DSB induction
and closure matters, we hypothesized that in Ku-deﬁcient
cells repair ﬁdelity decreases with increasing time. To
address this, GFP-positive cells were sorted 24 and 48h
after transfection and 186 individual repair junctions were
sequenced (Supplementary Figure S1). These two time
points, in particular, appeared suitable to pick up diﬀer-
ences between Ku-dependent and independent end-
joining. Most CHOK1 repair events were highly conser-
vative (Figure 3A and B). In many cases processing of the
non-compatible overhangs led to ﬁll-in of one additional
base (Figure 3A, deletion of  1bp). After 24 and 48h,
only few of the individual cells harvested showed deletions
of up to 22bp (one exception of 49bp in CHOK1-pEJ
after 24h). Notably, high repair ﬁdelity was maintained
independently of the time of cell harvest. In contrast,
nearly all xrs5 junctions showed substantial loss of
ﬂanking sequences, the amount of which drastically
increased between 24 and 48h reaching up to 123bp
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Figure 3. Fidelity of the alternative end-joining. After 24 or 48h of transfection, GFP
+cells were sorted and subjected to sequencing (Supplementary
Figure S1). Scatter plots show deletion length of all individual repair junctions of (A) non-cohesive (pEJ) or (B) cohesive ends (pEJ2). Deletions are
deﬁned as the sum of base pairs lost at both external DSB ends. The 34-bp internal pop-out between both I-SceI sites was not deﬁned as a deletion.
P-values indicate the signiﬁcance level of diﬀerences between 24 and 48h in xrs5 clones (Mann–Whitney test). (C) and (D) Distribution of length of
microhomologies used for formation of the repair junctions at both substrates. The 4-nt microhomologies employed by CHO-K1-pEJ2 cells
correspond to the unmodiﬁed 4-bp complementary overhangs created directly through I-SceI cleavage. Sequence results were pooled from
three independent sorting experiments for each cell line.
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mean deletion length almost doubled between 24 and 48h
(for xrs5-pEJ from 17±3 to 45±7bp and for xrs5-pEJ2
from 22.6±6 to 45.5±7.9bp, respectively), while it
remained constant in Ku-proﬁcient cells (Figure 3A
and B). Interestingly, neither in wild-type nor in
Ku-deﬁcient cells the structure of the DSBs aﬀected the
extent of base loss. Even full complementary overhangs
(pEJ2) did not provide suﬃcient stability to prevent end
degradation in xrs5 cells.
Sequence analyses (Supplementary Figure S1) demon-
strate that 85% of pEJ-repair junctions in CHOK1 cells
were formed upon using either no or one overlapping base
and only 15% by longer microhomologies (Figure 3C).
Xrs5 cells (Figure 3C and D, pEJ and pEJ2) used signiﬁ-
cantly more often two or more overlapping bases
compared to the wild-type (Fisher’s exact test,
P<0.001). However, the average length of micro-
homologies was not signiﬁcantly diﬀerent (1.03±0.09nt
for CHOK1-pEJ versus 1.8±0.3nt for xrs5-pEJ and
1.25±0.2nt xrs5-pEJ2) in contrast to previous reports
(7,16,32–34). CHOK-pEJ2 employed directly the 4-nt
complementary overhang resulting from double I-SceI
cleavage without further modifying the ends (Figure 3D,
see 4-nt column).
Together, our results revealed a slow but eﬃcient alter-
native end-joining mode in the absence of Ku. This
Ku-independent process is highly error-prone, as DSB
termini are subjects of continuous end degradation
before cells succeed to join the ends. Extended micro-
homologies are not required for eﬃcient end ligation in
xrs5 cells.
PARP1 inhibition sensitizes Ku80-deﬁcient cells to
ionizing radiation
The slow repair in xrs5 cells might reﬂect either the insuf-
ﬁcient classical end-joining in the absence of the critical
Ku component or alternatively another genetically distinct
end-joining pathway which operates slowly and inaccur-
ately as reported recently (20,21,26,35,36). Biochemical
studies and rejoining of episomal plasmids suggested
that PARP1 is involved together with ligase III, XRCC1
and PNK (4,19,20,25). However, it is hitherto not known
whether PARP1 is physically required for the alternative
rejoining of chromosomal breaks in vivo. To address this
question, we used chemical PARP inhibition as well as
PARP1 depletion strategies. Two PARP inhibitors were
used at non-toxic concentrations (Supplementary Figure
S2A and B). Both 75mM DIQ and 300mM NU1025 com-
pletely abrogated IR-induced nuclear accumulation of
poly(ADP)ribose (PAR) moieties (Figure 4A). However,
PARP-inhibition did not modulate survival of irradiated
CHOK1 cells (Figure 4B), while xrs5 cells were signiﬁcant-
ly radio-sensitized (1.9-fold). This suggests that inhibition
of PARP1 compromises the residual repair capacity in
Ku-deﬁcient cells.
PARP1 is physically required for alternative end-joining
In order to more speciﬁcally determine the impact upon
NHEJ, repair of I-SceI induced DSB was followed in the
presence of PARP inhibitors. DIQ only slightly reduced
the end-joining eﬃciency in CHOK1 cells (Figure 4C). In
contrast, successful end-joining was almost completely
abolished in xrs5 cells at 24 and 48h post-transfection,
suggesting that the slow alternative end-joining mode
requires functional PARP1. Similar results were
obtained for complementary and non-complementary
DSB ends (Figure 4C and Supplementary Figure S2C),
indicating that the end-structure does not modulate the
need for PARP1 when Ku80 is lacking.
PARP1 function not only includes rapid recruitment to
damaged sites but also its subsequent release from DNA
which is achieved through auto-modiﬁcation by loading of
(ADP)ribose-polymers (37). Exactly the latter function is
inhibited by DIQ (or NU1025), raising the possibility that
the inhibitors ‘freeze’ inactive PARP1 molecules in situ.
Un-rejoined DNA termini may then be blocked for any
further repair. In order to exclude this unspeciﬁc repres-
sive eﬀect, PARP1 was depleted in vivo by transient
knock-down and the repair eﬃciencies were again
measured 24 and 48h after DSB induction. siRNA treat-
ment 24h before I-SceI transfection reduced cellular
PARP1 content by >90% (Figure 4D and
Supplementary Figure S3), which, however, did not sig-
niﬁcantly aﬀect end-joining in wild-type cells at both time
points (Figure 4D and Supplementary Figure S2C).
Similar to PARP1 inhibition, its depletion in xrs5 cells
virtually precluded successful end-joining as measured by
lack of GFP-positive cells. Complementation of xrs5 cells
with hKU80 reverted the end-joining eﬃciency to a level
previously measured in CHOK1 (Figure 5, compare
columns 3 and 5). Besides, PARP1 depletion did no
longer exhibit a strong inhibitory eﬀect. The slightly
reduced end-joining eﬃciency (Figure 5, column 4) was
found to be of the same magnitude as in wild-type cells
(Figure 4D). These in vivo observations prove for the ﬁrst
time that PARP1 is physically needed to execute the alter-
native end-joining pathway in the absence of the
Ku-protein.
We next tested whether the switch to this alternative
end-joining mode is a general consequence of lacking
any of NHEJ core proteins or an exclusive response
when Ku is absent. To this end we transiently transfected
DNA-PK-deﬁcient V3 hamster cells and their parentals
(AA8) with I-SceI-linearized pEJ. Repair was then moni-
tored after 24and 48h in the presence or absence of DIQ.
Figure 6A shows that inhibition of PARP did not aﬀect
the end-joining in V3 cells suggesting that repair in this
case was not PARP-mediated. Wild-type cells experience
the same minor response to DIQ as seen before
(Figures 6A and 4C, see ‘Discussion’ section). It could
be speculated that the repair observed in mutant cells
(DNA-PKcs- and PARP-independent) is brought about
by XRCC4/LigIV. In line with this notion Ku-dependent
recruitment of XRCC4/LigIV was observed in DNA-
PKcs-deﬁcient cells (38). Virtually, identical results were
obtained with a second DNA-PKcs proﬁcient and deﬁ-
cient cell pair (CHO9 and XR-C1) (data not shown), con-
ﬁrming that not the end-joining defect per se (i.e. lack of
DNA-PKcs), but in particular the absence of Ku guides
the choice towards PARP1-dependent NHEJ.
6070 Nucleic Acids Research, 2010,Vol.38, No. 18It was previously shown that PARP1 may stimulate
DNA-PKcs kinase activity even in the absence of Ku
proteins (39). Hence, PARP1 might support DSB repair
by DNA-PKcs and perhaps other downstream core com-
ponents. In order to verify this possibility in xrs5 cells, we
inhibited DNA-PKcs by a potent inhibitor (NU7026)
which proved to inhibit classical end-joining as it eﬃcient-
ly sensitized CHOK1 but not xrs5 cells to IR
[Supplementary Figure S4 and (40,41)]. The presence of
NU7026 did not change the end-joining eﬃciency in xrs5
cells which fully rely on PARP1-mediated end-joining
(Figures 6C and 4C). Adding both PARP and
DNA-PKcs inhibitors simultaneously did not further
reduce the residual end-joining activity below the eﬀect
of the PARP inhibitor alone (Figure 6C). Thus, xrs5
cells do not use PARP1 to direct the repair into ‘classical’
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Figure 4. Alternative end-joining mechanism is PARP1-dependent. (A) xrs5 cells were X-irradiated (20Gy) and immunostained after 20min for
obtaining PAR. Pretreatment with the PARP-inhibitors (DIQ or NU1025) completely abrogated nuclear PAR accumulation. (B) Cell survival of
CHOK1 and xrs5 cells after X-irradiation (closed symbols, solid lines) alone or in the presence of either PARP inhibitor (open symbols, dashed lines)
was carried out. An amount of 75mM DIQ (asterisk) and 300mM NU1025 (diamonds) led to equal radiosensitization in xrs5 cells (dashed line), but
had almost no eﬀect on CHOK1 (open triangles). The mean values of three independent experiments are shown. Data were ﬁtted to the linear
quadratic equation S/S0=exp(– D– D
2). The parameters obtained ( ,  ) were used to calculate the mean inactivation dose, Dbar (87) as a measure
for the radiosensitivity. (C) NHEJ eﬃciency in the presence or absence of DIQ was determined as shown before (Figure 2) in CHOK1-pEJ and
xrs5-pEJ clones (CHOK1-pEJ #70 and 71, and xrs5-pEJ #20 and 26). DIQ, given immediately after I-SceI transfection, signiﬁcantly inhibited
end-joining eﬃciency only in xrs5 cells. Data show the mean (±SE) of two experiments performed with two clones and three replicates each. (D)
PARP1 was depleted from cells carrying pEJ by transient siRNA transfection 24h before end-joining experiments were started as described before.
(Immunoblot shows PARP1 expression 24h after siRNA treatment.) The signiﬁcant diﬀerence is indicated. sc indicates transfection with unspeciﬁc
‘scrambled’ siRNA. si indicates siRNA speciﬁcally targeting PARP1. Data show the mean (±SE) of two experiments performed with three replicates
using a single clone of each strain.
Nucleic Acids Research, 2010,Vol.38, No. 18 6071DNA-PK-dependent end-joining. The wild-type cells
showed moderately reduced repair upon DNA-PK inhib-
ition [Figure 6B; (29)], which could not be further reduced
when combined with PARP inactivation (Figure 6B).
Altogether these experiments demonstrate that PARP1 is
not signiﬁcantly involved in the DSB repair as long as Ku
is present. In the absence of Ku, the repair is directed to a
PARP1-dependent end-joining mode which, however,
does not require functional DNA-PKcs.
DISCUSSION
Alternative end-joining is slow and error-prone but not
dependent upon micro-homologies
Here we characterize an alternative mode of DSB
end-joining which received increasing attention during
the last years as a backup pathway in case classical
NHEJ is not operative (19,24). Chromosomal DSB were
rejoined independent of Ku and DNA-PKcs at markedly
slow kinetics. However, alternative end-joining ﬁnally
reaches eﬃciencies (fraction of GFP-positive cells in our
assay) comparable to those in Ku-proﬁcient wild-type cells
(Figure 2). A slow but widely complete repair of radiation
induced DSB was similarly found for hypomorphic ligase
IV and DNA-PKcs deletion mutants (42,43), suggesting
that the backup pathway is not restricted to enzymatic
breaks. However, this delayed repair option in
Ku80-deﬁcient cells does not confer radioresistance
(Figure 4) perhaps due to its error-proneness.
We observed extensive sequence loss at the junctions
(Figure 3), other studies described in addition frequent
chromosomal rearrangements resulting from alternative
end-joining (21–24,44).
Interestingly, we found that neither the eﬃciency nor
the ﬁdelity of NHEJ signiﬁcantly depends upon the end
structure. Wild-type cells rejoined cohesive and non-
cohesive ends equally well. Necessary modiﬁcations were
restricted to the 4-nt protrusions of the I-SceI-induced
DSB ends, representing the minimum eﬀort to render
overhangs ligatable. In Ku80-deﬁcient cells, the ends
were invariably degraded, fully compatible overhangs to
the same extent as non-compatible ends (Figure 3). The
deletion length increased with time, conﬁrming the pro-
tective function of the Ku-protein against nucleolytic deg-
radation (18,31,45,46). Again, degree of end modiﬁcation
and overall eﬃciency of Ku-independent end-joining was
not determined by the end structure. This result contrasts
to the recent observations in yeast and hamster cells which
suggested that only non-compatible ends are eﬃciently
repaired in the absence of Ku while complementary ends
absolutely require Ku (14–16,47). This discrepancy may be
partly due to the diﬀerent reporter constructs used or to
the small number (one to three) of clones investigated that
were not truly representative. The variation observed here
among the 10–13 independent clones of each kind (Figure
1A and B) illustrates the potential bias inherent in those
transgenic systems.
Alternative end-joining was also named
microhomology-mediated end-joining (MMEJ)
(14,21,33,34,48,49), suggesting that the requirement of
stretches of homology sequences (up to 8bp) is a
hallmark of this pathway and distinct from classical
end-joining. In contrast, we demonstrate here that
Ku-independent repair does not necessarily need extensive
microhomologies for eﬃcient ligation (Figure 3C). In
agreement with preceding studies including our own
(7,16–18,32–34,48), wild-type cells were found to use
mostly no or one overlapping base. Although 0/1-nt
overlap was used eﬃciently by Ku-deﬁcient cells
(Figure 3C), they signiﬁcantly more often employed
microhomologies of  2nt. However, the mean length of
microhomologies was not strikingly diﬀerent between
CHOK1 and xrs5 cells (1.03 versus 1.8nt, n.s.), although
our system included many options for longer
microhomologies of up to 7bp (Supplementary Figure
S5). Xrs5 cells simply did not use them for synapsis. On
the contrary, the best assessable homologous stretch, the
4-nt complementary overhang resulting directly from
I-SceI cleavage, was used only in wild-type (95% of
pEJ2 junctions, see Supplementary Figure S1), but not
in Ku80-deﬁcient cells. Similar observations were also
reported previously (13–16,31,34,48,50,51). We thus
conclude that usage of longer microhomologies is not a
distinct feature of the alternative end-joining (34,47,49).
Without Ku (or other core components), however, the
end degradation process may eventually expose longer
microhomologies which transiently enhance the stability
of the junction and hence facilitate the ligation (52–55).
It could well be that a favorable position of
microhomologies within reporter constructs bias repair
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Figure 5. Complementing the Ku defect abrogates the
PARP1-dependency of the end-joining process. Experiments were
performed as described earlier. Xrs5-pEJ cells (clone #20) were
co-transfected with I-SceI- and hKU80-expressing vectors (17) and
analyzed for GFP
+ after 24h. Reversion of the NHEJ capability in
xrs5 cells from three independent experiments was compared with the
mean of CHOK1-pEJ taken from Figure 2A.
6072 Nucleic Acids Research, 2010,Vol.38, No. 18towards MMEJ but eﬃcient ligation is not at all depend-
ent upon longer stretches of homologies.
Alternative end-joining requires functional PARP1
Recently, the base excision repair protein PARP1 was
appreciated as a potential component of alternative
end-joining (20,25) and class switch recombination (56).
Importantly, chemical PARP inhibitors compromised the
rejoining of episomal plasmids and chromosomal DSB in
Ku- and ligase-IV-deﬁcient but not in wild-type cells [(26);
Figure 4C]. To exclude an unspeciﬁc suppressive eﬀect
upon DSB rejoining we depleted PARP1 speciﬁcally by
siRNA and proved for the ﬁrst time that PARP1 is abso-
lutely required for the alternative Ku-independent
end-joining in vivo (Figure 4D). The fact that other
PARP isoforms were not co-depleted underscores the
unique role of PARP1 for this pathway. In contrast,
knock-down of ligase III, known to be involved in the
alternative end-joining (20,25), but also of ligase I or IV
and even combined depletion had a surprisingly moderate
eﬀect upon end-joining (57) either because low levels of
those proteins are suﬃcient for eﬀective NHEJ or due to
the functional overlap of the three ligases.
Recruitment of PARP1 to sites of DNA damage and
subsequent poly-(ADP)ribosylation of target proteins,
including itself, is a rapid process starting within seconds
and implicates PARP1 in the ATM-mediated DNA
damage response (37,58,59). PARP-automodiﬁcation has
a dual role: it ampliﬁes the DNA damage signal and at the
same time leads to dissociating PARP1 from the DNA
and hence to self-termination of the signal within 30min
(37). Here we ﬁnd PARP1 involved in a delayed and slow
repair process and propose a ‘second wave’ of PARP1
activity completely separated from initial signaling and
base excision repair.
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Figure 6. PARP1-dependent end-joining is hindered by the presence of Ku but not modulated by DNA-PKcs. Cells were treated with either DIQ
(75mM) or the DNA-PK-inhibitor NU7026 (15mM) or with both inhibitors simultaneously. (A) I-SceI was used to linearize pEJ plasmid in vitro of
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+ cells were measured as an indicator of the repair after 24and 48h with or without DIQ. (B) Experiments were performed as described
in Figure 4C. Inhibition of DNA-PKcs but not of PARP compromised the repair in CHOK1. (C) Inhibition of PARP but not of DNA-PK almost
completely inhibited the slow repair in xrs5 cells.
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DSB ends are occupied by Ku due to its high binding
aﬃnity (60) but presumably in competition with PARP1
(26). Ku virtually ‘blocks’ the entry to the PARP1-
dependent end-joining pathway which could well explain
that: (i) PARP-inhibition is not eﬀective when DNA-PK is
lacking but Ku is present [Figure 6C; (26)], (ii) alternative
end-joining in XRCC4 mutants is much less eﬃcient
(16,18,61) than in mutants lacking Ku and (iii) in ligase
IV
 /  cells end-joining eﬃciency and radioresistance
increase upon knockdown of Ku70 (26,62). In the latter
case PARP1 eﬃciently gets access to the DSB and directs
repair towards alternative end-joining (26). This competi-
tion model would on the other hand also predict that even
in the presence of Ku a small fraction of DSBs is repaired
by alternative end-joining, probably those DSBs that lead
to longer deletions (14% in CHOK1 cells, Figure 3A and
B). Consistent with this notion, PARP1 inactivation in
CHOK1 cells slightly reduces end-joining eﬃciency (on
average by 16% in Figures 4C, D and 6A). In addition
DNA-PK is a target of PARP1, poly(ADP)ribosylation
increases its kinase function and vice versa catalytically
dead PARP suppresses DNA-PK activity (39,63).
However, the signiﬁcance of these mechanisms is not
clear yet since neither general inhibition of DSB repair
nor radiosensitization were uniformly observed in
wild-type cells upon PARP inactivation [Figure 4B;
(26,63–68)].
Impact of Ku and PARP1 upon regulation of DSB
repair pathways
In a preceding paper we have shown that in the absence of
Ku DSB repair is not only channeled into alternative
end-joining but also towards single-strand annealing
(SSA) and homologous recombination (17). A common
theme of all three modes is the resection of primarily
50-DNA ends though to diﬀerent extents. Long-distance
resection of remote homologous repeats which is required
for SSA appears to be driven by ExoI, DNA2 and RecQ
family helicases (69,70). Limited removal up to 100nt is
achieved through Mre11 nuclease activity in line with CtIP
(69,71–73). Resulting stretches of 30ss-DNA constitute
intermediates for subsequent long-track resection
but may also directly serve as substrates for alternative
end-joining. Accordingly, both CtIP and Mre11
have been shown to be essential components of the
alternative end-joining (14,34,61,74–76). Interestingly,
PARP1 is a necessary recruitment factor of Mre11
and NBS1 and physically interacts with both proteins
(59). It is thus tempting to speculate that PARP1
may promote the resection step during alternative
end-joining beside its interaction with XRCC1, PNK
and ligase III (4,20,25). Regulation of resection may also
contribute to the impact of PARP1 upon homologous
recombination. The HR promoting role (77–80) was
hitherto explained by inactivating poly(ADP)ribosylation
of Ku which then dissociates from DNA ends leaving
space for HR and replication factors (79–81). However,
it is not known whether PARP1 could also stimulate
HR in the absence of Ku possibly by supporting end
resection.
CONCLUSION
Extending our previous observations (17,18) we conclude
that the majority of chromosomal DSB are repaired by
classical NHEJ in a rapid and highly accurate manner
(see model in Figure 7). In the absence of Ku, rather
than of other core components, repair is mainly channeled
to an alternative end-joining route which is slow,
error-prone and completely dependent upon PARP1.
The end synapsis appears to be facilitated by overlapping
bases but does not require longer microhomologies.
Besides alternative end-joining, Ku-deﬁcient cells used
SSA and intra-chromosomal gene conversion more fre-
quently than wild-type cells (17,34,82). All three repair
modes may compensate for the classical end-joining
defect but do not eﬀectively complement the
radiosensitivity probably due to the reduced repair
ﬁdelity.
Given its robustness and its error-prone character,
however, PARP1-dependent end-joining can be
considered to augment genetic instability and hence car-
cinogenesis (24). Support to this notion comes from
the fact that NHEJ-deﬁcient mice are characterized by
high rate of large deletions, translocations including
particularly those between the Ig heavy chain (IgH)
locus and c-Myc which frequently induce lymphomas
(23,56,83–86).
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Figure 7. Model of Ku-dependent and independent DSB repair. In the
presence of Ku, DSB repair is mainly executed by accurate NHEJ. A
minor fraction is normally also repaired by HR or SSA (17). In the
absence of Ku, repair is shuttled to all three other pathways which
likely share a common initial end resection step. The lack of Ku
binding leaves space for key proteins to bind such as PARP1, Rad51
or Rad52, respectively. The majority of DSBs are still repaired by
end-joining, however by an alternative PARP1-dependent mode.
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